Early Phase I Microdosing Study of ORM-14540 and ORM-12741

NCT00831077 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ORM-14540
DRUG: ORM-12741

Sponsor

Orion Corporation, Orion Pharma